Replies to post #41344 on Biotech Values

[DewDiligence]

> YMI CC – Commented about the trial being well run…<

LOL. The primary endpoint of the trial was survival—what was there to mess up?

> They will have about 80 million in cash (Canadian) / 2 years burn<

This is a real point of the entire Tesmilifene program, IMHO. Without the hype generated by the program, there’s no way YMI would have been able to raise that much cash and they’d probably have been out of business by now.

Maybe nimo will work and they’ll get a second life, but I’m with walkinizer on this: it’s not something I’d want to bet on.